RESUMO
Inflammatory myofibroblastic tumor (IMT) is a rare soft tissue tumor primarily occurring in the abdominopelvic region of young patients, and it is characterized by spindle-shaped myofibroblasts, or fibroblasts surrounded by inflammatory infiltrate. Herein, we report a case of a 24-year-old male with a firm submucosal mass in the anterior right vocal fold diagnosed as an IMT that recurred 14 months later. The tumor demonstrated a novel THBS1::ALK fusion containing Exons 1-7 of the thrombospondin 1 (THBS1) gene fused to Exon 19 of the anaplastic lymphoma kinase (ALK) gene via next-generation sequencing with the NextSeq sequencer. The fusion of THBS1 to ALK potentially results in increased expression and constitutive activation of the ALK kinase domain. These findings not only broaden the repertoire of known ALK fusion partners implicated in tumorigenesis but also provide a novel avenue for investigating the etiology of recurrent IMT by considering this fusion event as a causal factor. To our knowledge, this is the second case of IMT of the larynx with this novel mutation reported in the literature and the first such case with a detailed description of this specific fusion and clinical recurrence.
RESUMO
The pre-mRNA splicing factor PRP19 is recruited into the spliceosome after forming the PRP19/CDC5L complex in humans and the Nineteen complex in yeast. Additionally, 'PRP19-related' proteins enter the spliceosome individually or in pre-assemblies that differ in these systems. The protistan family Trypanosomatidae, which harbors parasites such as Trypanosoma brucei, diverged early during evolution from opisthokonts. While introns are rare in these organisms, spliced leader trans splicing is an obligatory step in mRNA maturation. So far, â¼70 proteins have been identified as homologs of human and yeast splicing factors. Moreover, few proteins of unknown function have recurrently co-purified with splicing proteins. Here we silenced the gene of one of these proteins, termed PRC5, and found it to be essential for cell viability and pre-mRNA splicing. Purification of PRC5 combined with sucrose gradient sedimentation revealed a complex of PRC5 with a second trypanosomatid-specific protein, PRC3, and PRP19-related proteins SYF1, SYF3 and ISY1, which we named PRP19-related complex (PRC). Importantly, PRC and the previously described PRP19 complex are distinct from each other because PRC, unlike PRP19, co-precipitates U4 snRNA, which indicates that PRC enters the spliceosome prior to PRP19 and uncovers a unique pre-organization of these proteins in trypanosomes.
Assuntos
Enzimas Reparadoras do DNA/genética , Proteínas Nucleares/genética , Proteínas de Protozoários/genética , Precursores de RNA/genética , Fatores de Processamento de RNA/genética , Proteínas de Saccharomyces cerevisiae/genética , Trypanosoma brucei brucei/genética , Enzimas Reparadoras do DNA/metabolismo , Humanos , Modelos Biológicos , Proteínas Nucleares/metabolismo , Ligação Proteica , Proteínas de Protozoários/metabolismo , Interferência de RNA , Precursores de RNA/metabolismo , Splicing de RNA , Fatores de Processamento de RNA/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , RNA de Protozoário/genética , RNA de Protozoário/metabolismo , RNA Nuclear Pequeno/genética , RNA Nuclear Pequeno/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Spliceossomos/genética , Spliceossomos/metabolismo , Trypanosoma/classificação , Trypanosoma/genética , Trypanosoma/metabolismo , Trypanosoma brucei brucei/metabolismoRESUMO
Known transcription factors of trypanosomatid organisms are extremely divergent in amino acid sequence to their counterparts in other eukaryotes. Sequence similarity is so limited that factors have been primarily identified by functional and structural studies. In addition, trypanosomatids may have evolved factors that are specific to this group of organisms. Under these circumstances, an in vitro transcription system is invaluable as it allows for unambiguous determination of a factor's transcriptional role. Here we describe procedures for the preparation of transcriptionally active extracts, detail in vitro transcription reactions, and specify the particular strategy necessary to detect template-derived RNA in this system. As examples of how to use this system, we describe factor depletion from extract and antibody-mediated interference with a factor's transcriptional function. Furthermore, we detail a promoter pull-down assay that makes use of the extracts and facilitates analysis of a factor's interaction with promoter DNA.
Assuntos
Parasitologia/métodos , Proteínas de Protozoários/análise , Fatores de Transcrição/análise , Transcrição Gênica , Trypanosomatina/genética , Regulação da Expressão Gênica , Immunoblotting/métodos , Regiões Promotoras Genéticas/genética , Proteínas de Protozoários/genética , Proteínas de Protozoários/metabolismo , RNA de Protozoário/isolamento & purificação , RNA de Protozoário/metabolismo , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismoRESUMO
Trypanosoma brucei CRK9 is an essential cyclin-dependent kinase for the parasite-specific mode of pre-mRNA processing. In trypanosomes, protein coding genes are arranged in directional arrays that are transcribed polycistronically, and individual mRNAs are generated by spliced leader trans-splicing and polyadenylation, processes that are functionally linked. Since CRK9 silencing caused a decline of mRNAs, a concomitant increase of unspliced pre-mRNAs and the disappearance of the trans-splicing Y structure intermediate, CRK9 is essential for the first step of splicing. CRK9 depletion also caused a loss of phosphorylation in RPB1, the largest subunit of RNA polymerase (pol) II. Here, we established cell lines that exclusively express analog-sensitive CRK9 (CRK9AS ). Inhibition of CRK9AS in these cells by the ATP-competitive inhibitor 1-NM-PP1 reproduced the splicing defects and proved that it is the CKR9 kinase activity that is required for pre-mRNA processing. Since defective trans-splicing was detected as early as 5 min after inhibitor addition, CRK9 presumably carries out reversible phosphorylation on the pre-mRNA processing machinery. Loss of RPB1 phosphorylation, however, took 12-24 hr. Surprisingly, RNA pol II-mediated RNA synthesis in 24 hr-treated cells was upregulated, indicating that, in contrast to other eukaryotes, RPB1 phosphorylation is not a prerequisite for transcription in trypanosomes.